A pulverulent semisynthetic material, derived from a natural marine biomaterial, namely the aragonitic inner layer of the shell of bivalve molluscs selected from Pinctadines, notably Pinctada maxima, margaritifera, and Tridacnes, notably Tridacna gigas, maxima, derasa, tevaroa, squamosa, crocea, Hippopus hippopus, Hippopus porcelanus, in pulverulent form, with the addition of insoluble and soluble biopolymers and calcium carbonate transformed by carbonation.

This invention is related to the field of medical device implants. In particular, the invention is related to sutures and antibacterial coatings that comprise collagen. In particular, some of the collagen-based coatings prevent and control of bacterial infections that result from the use of medical device implants (e.g., head and neck implants). One method of preventing post-medical device implant bacterial infections comprises using a medical device coated with a biologic antimicrobial coating. For example, one such coating comprises a covalently crosslinked heparin-collagen sheet.

This invention is related to the field of medical device implants. In particular, the invention is related to sutures and antibacterial coatings that comprise collagen. In particular, some of the collagen-based coatings prevent and control of bacterial infections that result from the use of medical device implants (e.g., head and neck implants). One method of preventing post-medical device implant bacterial infections comprises using a medical device coated with a biologic antimicrobial coating. For example, one such coating comprises a covalently crosslinked heparin-collagen sheet.

This invention is related to the field of medical device implants. In particular, the invention is related to sutures and antibacterial coatings that comprise collagen. In particular, some of the collagen-based coatings prevent and control of bacterial infections that result from the use of medical device implants (e.g., head and neck implants). One method of preventing post-medical device implant bacterial infections comprises using a medical device coated with a biologic antimicrobial coating. For example, one such coating comprises a covalently crosslinked heparin-collagen sheet.

A pulverulent semisynthetic material, derived from a natural marine biomaterial, namely the aragonitic inner layer of the shell of bivalve molluscs selected from the group including Pinctadines, notably Pinctada maxima, margaritifera, and Tridacnes, notably Tridacnagigas, maxima, derasa, tevaroa, squamosa, crocea, Hippopushippopus, Hippopusporcelanus, in pulverulent form, with addition of insoluble and soluble biopolymers and calcium carbonate transformed by carbonation; it also relates to the method of preparation thereof and to the uses thereof.

A pulverulent semisynthetic material, derived from a natural marine biomaterial, namely the aragonitic inner layer of the shell of bivalve molluscs selected from the group including Pinctadines, notably Pinctada maxima, margaritifera, and Tridacnes, notably Tridacnagigas, maxima, derasa, tevaroa, squamosa, crocea, Hippopushippopus, Hippopusporcelanus, in pulverulent form, with addition of insoluble and soluble biopolymers and calcium carbonate transformed by carbonation; it also relates to the method of preparation thereof and to the uses thereof.

The present invention relates, in part, to sutures which promote wound closure and/or healing. In particular, the present invention provides fibrin microthread sutures that mimic the mechanical behavior of a target tissue thereby reducing, for example, scarring, inflammation, and cell death at the ligature site, including monofilament sutures.

The present invention relates, in part, to sutures which promote wound closure and/or healing. In particular, the present invention provides fibrin microthread sutures that mimic the mechanical behavior of a target tissue thereby reducing, for example, scarring, inflammation, and cell death at the ligature site, including monofilament sutures.

The present disclosure describes methods of treating an injury in a subject using placental tissue streamers, engineered tissue placental tissue hybrids, suture placental tissue hybrids, placental tissue patch hybrids, and tissue hybrids, and the use of these compositions to repair, treat, or support an injury or degenerative process in a subject.

The present disclosure describes methods of treating an injury in a subject using placental tissue streamers, engineered tissue placental tissue hybrids, suture placental tissue hybrids, placental tissue patch hybrids, and tissue hybrids, and the use of these compositions to repair, treat, or support an injury or degenerative process in a subject.